Goldman Sachs’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.63M | Buy |
230,999
+32,165
| +16% | +$413K | ﹤0.01% | 4176 |
|
|
2026
Q1 | $1.65M | Sell |
198,834
-10,468
| -5% | -$94.6K | ﹤0.01% | 4704 |
|
|
2025
Q4 | $2.01M | Buy |
209,302
+43,196
| +26% | +$408K | ﹤0.01% | 4582 |
|
|
2025
Q3 | $1.57M | Buy |
166,106
+58,585
| +54% | +$493K | ﹤0.01% | 4684 |
|
|
2025
Q2 | $802K | Sell |
107,521
-22,624
| -17% | -$140K | ﹤0.01% | 4854 |
|
|
2025
Q1 | $791K | Sell |
130,145
-77,969
| -37% | -$539K | ﹤0.01% | 4866 |
|
|
2024
Q4 | $1.62M | Buy |
208,114
+50,771
| +32% | +$378K | ﹤0.01% | 4474 |
|
|
2024
Q3 | $1.28M | Sell |
157,343
-6,811
| -4% | -$55.7K | ﹤0.01% | 4468 |
|
|
2024
Q2 | $1.13M | Buy |
164,154
+28,858
| +21% | +$389K | ﹤0.01% | 4351 |
|
|
2024
Q1 | $2.39M | Sell |
135,296
-51,266
| -27% | -$812K | ﹤0.01% | 3741 |
|
|
2023
Q4 | $2.89M | Sell |
186,562
-37,190
| -17% | -$486K | ﹤0.01% | 3633 |
|
|
2023
Q3 | $3.07M | Sell |
223,752
-60,313
| -21% | -$888K | ﹤0.01% | 3411 |
|
|
2023
Q2 | $4.9M | Buy |
284,065
+32,463
| +13% | +$664K | ﹤0.01% | 3127 |
|
|
2023
Q1 | $6.04M | Buy |
251,602
+32,448
| +15% | +$706K | ﹤0.01% | 2878 |
|
|
2022
Q4 | $3.8M | Buy |
219,154
+32,486
| +17% | +$685K | ﹤0.01% | 3415 |
|
|
2022
Q3 | $4.55M | Buy |
186,668
+33,271
| +22% | +$1.15M | ﹤0.01% | 3212 |
|
|
2022
Q2 | $4.75M | Sell |
153,397
-38,231
| -20% | -$1.02M | ﹤0.01% | 3183 |
|
|
2022
Q1 | $6.69M | Sell |
191,628
-19,231
| -9% | -$727K | ﹤0.01% | 3077 |
|
|
2021
Q4 | $12.5M | Buy |
210,859
+94,076
| +81% | +$6.51M | ﹤0.01% | 2552 |
|
|
2021
Q3 | $7.77M | Sell |
116,783
-778
| -0.7% | -$48K | ﹤0.01% | 2964 |
|
|
2021
Q2 | $7.42M | Sell |
117,561
-5,170
| -4% | -$291K | ﹤0.01% | 2987 |
|
|
2021
Q1 | $6.38M | Buy |
122,731
+9,294
| +8% | +$565K | ﹤0.01% | 2920 |
|
|
2020
Q4 | $4.98M | Sell |
113,437
-16,628
| -13% | -$792K | ﹤0.01% | 3002 |
|
|
2020
Q3 | $6.17M | Buy |
130,065
+103,194
| +384% | +$4.18M | ﹤0.01% | 2734 |
|
|
2020
Q2 | $813K | Sell |
26,871
-15,184
| -36% | -$338K | ﹤0.01% | 4097 |
|
|
2020
Q1 | $718K | Sell |
42,055
-51,969
| -55% | -$910K | ﹤0.01% | 3978 |
|
|
2019
Q4 | $1.55M | Buy |
94,024
+35,106
| +60% | +$522K | ﹤0.01% | 3830 |
|
|
2019
Q3 | $964K | Buy |
58,918
+46,767
| +385% | +$937K | ﹤0.01% | 4057 |
|
|
2019
Q2 | $223K | Sell |
12,151
-9,449
| -44% | -$150K | ﹤0.01% | 4741 |
|
|
2019
Q1 | $279K | Buy |
+21,600
| New | +$235K | ﹤0.01% | 4663 |
|
|
2018
Q4 | – | Sell |
-28,675
| Closed | -$367K | – | 5297 |
|
|
2018
Q3 | $367K | Buy |
+28,675
| New | +$409K | ﹤0.01% | 4591 |
|
|
2018
Q2 | – | Sell |
-168,672
| Closed | -$1.45M | – | 5716 |
|
|
2018
Q1 | $1.45M | Buy |
168,672
+150,680
| +837% | +$1.33M | ﹤0.01% | 3804 |
|
|
2017
Q4 | $155K | Buy |
+17,992
| New | +$141K | ﹤0.01% | 5546 |
|
Other funds holding CYRX
CCM
FAM
MCO
Goldman Sachs's CYRX Position: Q2 2026 in Review
Goldman Sachs increased its CryoPort (CYRX) stake by 16% in Q2 2026, buying an estimated $413K and bringing the position to 230,999 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #4176.
Goldman Sachs first reported a position in CYRX in Q4 2017 and has held it in 33 quarters since. The position peaked at $12.5M in Q4 2021. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.
- Goldman Sachs held 230,999 shares of CryoPort worth $3.63M as of Q2 2026.
- Goldman Sachs bought 32,165 CryoPort shares in Q2 2026, an estimated $413K.
- CryoPort made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4176 holding.
- Goldman Sachs first reported a position in CryoPort in Q4 2017 and has held it in 33 quarters since.
- Goldman Sachs's CryoPort position peaked at $12.5M in Q4 2021.
- 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.